Skip to content
Home/Companies/Biotech/Metabogen

Metabogen

Biotech·Sweden·Exited 2021·Held 10yr
Entry
2011
Hold
10yr
Exit
2021

Who owns Metabogen?

Metabogen is a Swedish Biotech company, now owned by BioGaia, which acquired it in 2021 from GU Ventures.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
BioGaia
Exit Year
2021

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
ClimateTechSweden· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Metabogen?

Metabogen is now owned by BioGaia, which acquired it in 2021 from GU Ventures.

When did BioGaia acquire Metabogen?

BioGaia acquired Metabogen in 2021, buying from GU Ventures.

Who did Metabogen sell to?

GU Ventures sold Metabogen to BioGaia in 2021 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue